Diagnostic value of serum level of Gal-3, VASH-1 and NGAL for early renal dysfunction in women with gestational diabetes mellitus

doi:10.16352/j.issn.1001-6325.2026.03.0421

Abstract

Abstract: Objective To explore the diagnostic value of serum galectin-3 (Gal-3), vasohibin-1 (VASH-1) and neutrophil gelatinase associated lipocalin (NGAL) for early diagnosis of renal dysfunction in women with gestational diabetes mellitus (GDM). Methods A total of 96 GDM patients admitted to Jinhua People′s Hospital of Zhejiang Province from June 2023 to July 2024 were selected as the observation group, and 96 pregnant women with normal prenatal examination during the same period were selected as the control group. ELISA method was used to detect the serum level of Gal-3, VASH-1 and NGAL. According to the content of albumin in the urine of the patients at 24 h, the observation group was divided into diabetic nephropathy group and diabetic group. Pearson method to analyze correlations; Logistic regression analysis of related factors; ROC curves were used to predict performance. Results Glycosylated hemoglobin, low-density lipoprotein, high-density lipoprotein and fasting blood glucose level in patients with gestational diabetes and the serum level of Gal-3, VASH-1 and NGAL in patients with gestational diabetes mellitus were higher than those in the control group(P＜0.05). The serum level of Gal-3 and VASH-1, was positively correlated , serum level of Gal-3 and NGAL, serum level of VASH-1 and NGAL were all positively correlated (P＜0.001). The level of fasting blood glucose, serum Gal-3, VASH-1 and NGAL in the diabetic nephropathy group were significantly higher than those in the diabetic group (P＜0.05). High level of serum Gal-3, VASH-1 and NGAL were independent risk factors for early renal impairment in patients with GDM(P＜0.05). The serum level of Gal-3, VASH-1 and NGAL and the area under the curve (AUC) of the combined prediction of early renal impairment in patients were 0.853, 0.678, 0.865 and 0.955, respectively. Conclusions The serum level of Gal-3, VASH-1 and NGAL in GDM patients is increased especially the patients with early renal impairment. The prediction of triple combination for early renal impairment in GDM patients is more effective than that of patients with GDM alone.

Key words: galectin-3, vasohibin-1, neutrophil gelatinase associated lipocalin, gestational diabetes mellitus, early renal dysfunction

CLC Number:

R714.246

WANG Qianchen, SHI Xingchi, ZHENG Weiying. Diagnostic value of serum level of Gal-3, VASH-1 and NGAL for early renal dysfunction in women with gestational diabetes mellitus[J]. Basic & Clinical Medicine, 2026, 46(3): 421-426.

References

[1] Lende M, Rijhsinghani A. gestational diabetes: overview with emphasis on medical management[J]. Int J Environ Res Public Health, 2020, 17:9573-9582.
[2] 张丽娜, 贾梦涛, 孙泽云, 等. miR-483-3p在妊娠期糖尿病患者血清中的表达及临床意义 [J]. 基础医学与临床, 2025, 45:91-97.
[3] Ye W, Luo C, Huang J, et al. Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis[J]. BMJ, 2022, 25:e067946-e067953.
[4] Soares LC, Al-dalahmah O, Hillis J, et al. Novel galectin-3 roles in neurogenesis, inflammation and neurological diseases[J]. Cells, 2021, 10:3047-3057.
[5] Boutin L, Dépret F, Gayat e, et al. Galectin-3 in kidney diseases: from an old protein to a new therapeutic target[J]. Int J Mol Sci, 2022, 23:3124-3129.
[6] 王经忠, 张亮, 靳久增. 血清VASH-1、VEGF对非心源性栓塞性卒中患者近期预后的预测价值[J]. 河南医学研究, 2024, 33:85-89.
[7] Liu H, Wang D, Tang J, et al. Differences and clinical significance of serum 25-hydroxyvitamin d3 and vasohibin-1 (vash-1) levels in patients with diabetic nephropathy and different renal injuries[J]. Diabetes Metab Syndr Obes, 2023, 16:1085-1091.
[8] Romejko K, Markowska M, Niemczyk S. The review of current knowledge on neutrophil gelatinase-associated lipocalin (NGAL)[J]. Int J Mol Sci, 2023, 24:10470-10478.
[9] 黄俊巧, 李映桃, 刘梦玥, 等. 2022年中国妊娠期高血糖诊治指南与美国糖尿病学会妊娠合并糖尿病诊治指南比较[J]. 国际妇产科学杂志, 2022, 49:691-699.
[10] 杨静. 血清Gal-3指标在诊治糖尿病合并慢性肾脏疾病方面的临床意义[J]. 当代医药论丛, 2015, 11:64-65.
[11] Ren H, Shao Y, Ma X, et al. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios[J]. J Diabetes Complicat, 2019, 33:477-484.
[12] Ren H, Shao Y, Wu C, et al. VASH-1 regulates oxidative stress and fibrosis in diabetic kidney disease via SIRT1/HIF1α and TGFβ1/SMAD3 signaling pathways[J]. Front Mol Biosci, 2020, 10:137-145.